StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Jazz Pharmaceuticals (JAZZ) Reports Submission of Marketing Authorization Application to European Medicines Agency for Solriamfetol
November 9, 2018 5:53 AM
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA
Management Comments
Next Articles
Jazz Pharmaceuticals Submits Marketing Authorization Application to European Medicines Agency for Solriamfetol as a Treatment to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adult Pa
November 9, 2018 2:00 AM
Jazz Pharmaceuticals (JAZZ) PT Lowered to $190 at B.Riley/FBR
November 8, 2018 4:17 AM
Pre-Open Movers 11/07: (TWLO) (ARRS) (GNC) Higher; (MDXG) (INFN) (INGN) Lower (more...)
November 7, 2018 9:31 AM
Jazz Pharmaceuticals (JAZZ) PT Lowered to $200 at Cowen
November 7, 2018 8:57 AM
Jazz Pharmaceuticals (JAZZ) PT Lowered to $203 at BMO Capital
November 7, 2018 8:56 AM
Jazz Pharmaceuticals (JAZZ) PT Lowered to $184 at RBC Capital
November 7, 2018 7:22 AM
Jazz Pharmaceuticals (JAZZ) PT Lowered to $208 at Piper Jaffray
November 7, 2018 4:37 AM
